These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35217280)

  • 61. Two-year interim results from a 5-year study evaluating clinical recurrence of superficial basal cell carcinoma after treatment with imiquimod 5% cream daily for 6 weeks.
    Quirk C; Gebauer K; Owens M; Stampone P
    Australas J Dermatol; 2006 Nov; 47(4):258-65. PubMed ID: 17034468
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Nudging epidermal field cancerogenesis by imiquimod.
    Uhoda I; Quatresooz P; Piérard-Franchimont C; Piérard GE
    Dermatology; 2003; 206(4):357-60. PubMed ID: 12771486
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe.
    Schulze HJ; Cribier B; Requena L; Reifenberger J; Ferrándiz C; Garcia Diez A; Tebbs V; McRae S
    Br J Dermatol; 2005 May; 152(5):939-47. PubMed ID: 15888150
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pilot study of imiquimod 5% cream as adjunctive therapy to curettage and electrodesiccation for nodular basal cell carcinoma.
    Spencer JM
    Dermatol Surg; 2006 Jan; 32(1):63-9. PubMed ID: 16393600
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study.
    Geisse JK; Rich P; Pandya A; Gross K; Andres K; Ginkel A; Owens M
    J Am Acad Dermatol; 2002 Sep; 47(3):390-8. PubMed ID: 12196749
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient.
    Kagy MK; Amonette R
    Dermatol Surg; 2000 Jun; 26(6):577-8; discussion 578-9. PubMed ID: 10848940
    [TBL] [Abstract][Full Text] [Related]  

  • 67. An open-label, pilot study examining the efficacy of curettage followed by imiquimod 5% cream for the treatment of primary nodular basal cell carcinoma.
    Wu JK; Oh C; Strutton G; Siller G
    Australas J Dermatol; 2006 Feb; 47(1):46-8. PubMed ID: 16405483
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Successful treatment of basal cell carcinoma on the face with imiquimod 5% cream.
    Oster-Schmidt C; Altmeyer P; Stücker M
    Acta Derm Venereol; 2002; 82(6):477. PubMed ID: 12575864
    [No Abstract]   [Full Text] [Related]  

  • 69. Cryosurgery is more effective in the treatment of primary, non-superficial basal cell carcinomas when applied during and not prior to a five week imiquimod course: a randomized, prospective, open-label study.
    Gaitanis G; Alexopoulos EC; Bassukas ID
    Eur J Dermatol; 2011; 21(6):952-8. PubMed ID: 21926038
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Successful treatment and management of large superficial basal cell carcinomas with topical imiquimod 5% cream: a case series and review.
    Lacarrubba F; Potenza MC; Gurgone S; Micali G
    J Dermatolog Treat; 2011 Dec; 22(6):353-8. PubMed ID: 21781010
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An open case series of patients with basal cell carcinoma treated with topical 5% imiquimod cream.
    Cowen E; Mercurio MG; Gaspari AA
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S240-8. PubMed ID: 12271286
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Treatment of an extensive superficial basal cell carcinoma of the face with imiquimod 5% cream.
    Micali M; Nasca MR; Musumeci ML
    Int J Tissue React; 2005; 27(3):111-4. PubMed ID: 16372477
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Three-Year Follow-Up Results of Photodynamic Therapy vs. Imiquimod vs. Fluorouracil for Treatment of Superficial Basal Cell Carcinoma: A Single-Blind, Noninferiority, Randomized Controlled Trial.
    Roozeboom MH; Arits AHMM; Mosterd K; Sommer A; Essers BAB; de Rooij MJM; Quaedvlieg PJF; Steijlen PM; Nelemans PJ; Kelleners-Smeets NWJ
    J Invest Dermatol; 2016 Aug; 136(8):1568-1574. PubMed ID: 27113429
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial.
    Brown VL; Atkins CL; Ghali L; Cerio R; Harwood CA; Proby CM
    Arch Dermatol; 2005 Aug; 141(8):985-93. PubMed ID: 16103328
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tumor thickness and adnexal extension of superficial basal cell carcinoma (sBCC) as determinants of treatment failure for methylaminolevulinate (MAL)-photodynamic therapy (PDT), imiquimod, and 5-fluorouracil (FU).
    Roozeboom MH; van Kleef L; Arits AH; Mosterd K; Winnepenninckx VJ; van Marion AM; Nelemans PJ; Kelleners-Smeets NW
    J Am Acad Dermatol; 2015 Jul; 73(1):93-8. PubMed ID: 25935596
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sustained clearance of superficial basal cell carcinomas treated with imiquimod cream 5%: results of a prospective 5-year study.
    Quirk C; Gebauer K; De'Ambrosis B; Slade HB; Meng TC
    Cutis; 2010 Jun; 85(6):318-24. PubMed ID: 20666194
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Topical application of imiquimod for the treatment of high-risk facial basal cell carcinoma in Gorlin syndrome.
    Vereecken P; Monsieur E; Petein M; Heenen M
    J Dermatolog Treat; 2004 Apr; 15(2):120-1. PubMed ID: 15204165
    [No Abstract]   [Full Text] [Related]  

  • 78. Imiquimod: new indication. Basal cell carcinoma: inferior to other treatments.
    Prescrire Int; 2006 Aug; 15(84):130-1. PubMed ID: 16989024
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Eruptive epidermoid cysts during topical imiquimod treatment].
    Dillies AS; Gras-Champel V; Fraitag-Spinner S; Al Saïf F; Carmi E
    Ann Dermatol Venereol; 2017 Mar; 144(3):212-215. PubMed ID: 27765414
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Imiquimod and pulmonary embolism: a case report.
    Leroy B; Richez A; Wolf F; Descotes J; Vial T
    Therapie; 2014; 69(2):180-1. PubMed ID: 24926639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.